Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Antifungal action" is a general term referring to the variety of molecular mechanisms by which drugs or agents act to inhibit the growth of, or kill, fungal organisms. This includes targeting key fungal-specific pathways or structures such as cell wall synthesis (e.g., β-1,3-glucan synthase), cell membrane ergosterol synthesis (e.g., 14-alpha demethylase, squalene epoxidase), mitochondrial function, and fungal DNA or protein synthesis[2][4][7]. It is not the name of a specific molecule, protein, receptor, or conventional drug target, but rather a descriptor of function/mechanism that can be mediated through many distinct molecular targets. Key note: If you are seeking information about a specific *antifungal drug target* (e.g., "ergosterol", "glucan synthase", or "14-alpha demethylase"), please specify the exact protein or pathway. "Antifungal action" is too broad and does not designate a unique target[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antifungal action.